* Neurex Corp., of Menlo Park, Calif., submitted a new drugapplication with the FDA for marketing approval of Corlopam(fenoldopam mesylate) for blood pressure control in surgicalprocedures and for malignant hypertension. Neurex licensed the drugfrom SmithKline Beecham plc, of London.

(c) 1997 American Health Consultants. All rights reserved.

No Comments